Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 1
2006 1
2007 4
2008 1
2009 2
2010 2
2011 4
2012 1
2013 5
2014 6
2015 6
2016 6
2017 9
2018 8
2019 6
2020 7
2021 7
2022 7
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
The physiology of movement.
Goossens S, Wybouw N, Van Leeuwen T, Bonte D. Goossens S, et al. Mov Ecol. 2020 Feb 4;8:5. doi: 10.1186/s40462-020-0192-2. eCollection 2020. Mov Ecol. 2020. PMID: 32042434 Free PMC article. Review.
ZEB2 in T-cells and T-ALL.
De Coninck S, Berx G, Taghon T, Van Vlierberghe P, Goossens S. De Coninck S, et al. Among authors: goossens s. Adv Biol Regul. 2019 Dec;74:100639. doi: 10.1016/j.jbior.2019.100639. Epub 2019 Jul 27. Adv Biol Regul. 2019. PMID: 31383581 Review.
Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target.
Jonckheere S, Adams J, De Groote D, Campbell K, Berx G, Goossens S. Jonckheere S, et al. Among authors: goossens s. Cells Tissues Organs. 2022;211(2):157-182. doi: 10.1159/000512218. Epub 2021 Jan 5. Cells Tissues Organs. 2022. PMID: 33401271 Free article. Review.
Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids.
Lasolle H, Schiavo A, Tourneur A, Gillotay P, de Faria da Fonseca B, Ceolin L, Monestier O, Aganahi B, Chomette L, Kizys MML, Haenebalcke L, Pieters T, Goossens S, Haigh J, Detours V, Maia ALS, Costagliola S, Romitti M. Lasolle H, et al. Among authors: goossens s. Oncogene. 2024 Jan;43(3):155-170. doi: 10.1038/s41388-023-02889-y. Epub 2023 Nov 20. Oncogene. 2024. PMID: 37985676 Free PMC article.
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.
Nunes C, Depestel L, Mus L, Keller KM, Delhaye L, Louwagie A, Rishfi M, Whale A, Kara N, Andrews SR, Dela Cruz F, You D, Siddiquee A, Cologna CT, De Craemer S, Dolman E, Bartenhagen C, De Vloed F, Sanders E, Eggermont A, Bekaert SL, Van Loocke W, Bek JW, Dewyn G, Loontiens S, Van Isterdael G, Decaesteker B, Tilleman L, Van Nieuwerburgh F, Vermeirssen V, Van Neste C, Ghesquiere B, Goossens S, Eyckerman S, De Preter K, Fischer M, Houseley J, Molenaar J, De Wilde B, Roberts SS, Durinck K, Speleman F. Nunes C, et al. Among authors: goossens s. Sci Adv. 2022 Jul 15;8(28):eabn1382. doi: 10.1126/sciadv.abn1382. Epub 2022 Jul 13. Sci Adv. 2022. PMID: 35857500 Free PMC article.
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
Soen B, Vandamme N, Berx G, Schwaller J, Van Vlierberghe P, Goossens S. Soen B, et al. Among authors: goossens s. Hemasphere. 2018 May 11;2(3):e43. doi: 10.1097/HS9.0000000000000043. eCollection 2018 Jun. Hemasphere. 2018. PMID: 31723771 Free PMC article. Review.
83 results